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were isolated using either CBC alone or plus conventional radio-
frequency ablation. The AF-free survival had no signiﬁcant difference
between 23- and 28- mm groups (84.2% vs. 76.5%, P ¼ 0.726) during a
mean follow-up of 7.9  3.2 months. The complication rate was not
signiﬁcantly different between the two groups (2.5%vs.10.5%, P ¼
0.195). One case of phrenic nerve palsy was detected when froze with
a 28- mm balloon.
CONCLUSIONS CBC ablations using 23- mm balloons can simplify the
procedure, and achieve a higher acute efﬁcacy without at the cost of
safety in selected patients when compared with 28- mm ones for
catheter ablation of AF in China.
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OBJECTIVES Thromboembolic stroke is the most devastating compli-
cation of atrial ﬁbrillation. Occlusion of the left atrial appendage (LAA)
is believed to decrease the risk of stroke in the patients with non-
valvular atrial ﬁbrillation. LAA closure with WACTHMAN device was
authorized to prevent stroke in the patients with atrial ﬁbrillation,
replacing the traditional warfarin anticoagulants. LAmbre, a domestic
new-design double-disc LAA closure device and Lefort, a new-design
WATCHMAN-like device both entered into clinical trials, however, the
feasibility and safety should be further measured. The purpose of this
early clinical study was to determine the safety and efﬁcacy of LAA
closure using domestic LAA closure devices, the LAmbre and Lefort.
METHODS From April of 2014 to March of 2015, the patients with
atrial ﬁbrillation were enrolled to undergo percutaneous LAA closure
using the LAmbre or Lefort device. LAA closure was conﬁrmed by
transesophageal echocardiography (TEE), then TEE or transthoracic
transesophageal echocardiography (TTE) in the follow-up duration
within 7 days, at 1 month, 3 months, 6 months and 1 year post-LAA
closure. The success of sealing was deﬁned as there was no or mild
peri-device leak (jet <5mm) detected by TEE.
RESULTS Sixty-two patients were screened out to be conducted the
procedure of LAA closure using LAmbre (54 cases) and Lefore (8 cases)
respectively. Among all patients, 48 (77.4%) had permanent or
persistent atrial ﬁbrillation. The average CHADS2 score was 2.91.1
and the HAS-BLED was 3.31.0. The average time-cost of the proce-
dure was about 68 minutes. The success of LAA closure was 100%.
There were no major safety endpoint events during the peri-operative
period. The average follow-up duration was 8.6 months, of which The
LAmbre was 9.6 months, while the Lefort was 2 months. No cases lost
to follow up. The closure of LAA measured by TEE in the 3-month was
97.9%. No stroke event or device-associated severe adverse event
happened. The major SAEs were all-cause readmission (60%) and
approach-associated complications (33.3%).
CONCLUSIONS This single-center early clinical study showed the
safety and effectiveness to prevent stroke in the patients with atrial
ﬁbrillation for the procedure of LAA closure using using domestic
devices, the LAmbre or Lefort. However, further large cases and
longer follow-up visiting was still request.
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OBJECTIVES The aim of this study was to determine the mechanisms
and effectiveness of pulmonary antrum radial-linear (PAR) ablation in
comparison with pulmonary vein isolation (PVI) in patients with
paroxysmal atrial ﬁbrillation (AF) after a long-term follow-up.METHODS The enrollment occurred between March, 2011, and
August, 2011, with the last follow-up in May, 2014A total of 133 pa-
tients with documented paroxysmal AF were enrolled from 5 centers
and randomized to PAR group or PVI group. Event ECG recorder and
Holter monitoring were conducted during the follow-up for all
patients.
RESULTS The average procedure time was 15123 min in PAR group
and 17843 min in PVI group (P <0.001). The average ﬂuoroscopy
time was 217 min in PAR group and 2711 min in PVI group
(P ¼ 0.002). AF triggering foci were eliminated in 59 patients
(89.4%) in PAR group, whereas, only 4 patients (6.0%) in PVI group
(P <0.001). At median 36 (37-35) months of follow-up after single
ablation procedure, 43 of 66 patients in PAR group (65%) and 28 of
67 patients in PVI group (42%) had no recurrence of AF off anti-
arrhythmic drug (AAD) (P ¼0.007); and 47 of 66 patients in PAR
group (71%) and 32 of 67 patients in PVI group (48%) had no
recurrence of AF with AAD (P ¼0.006). At the last follow-up, the
burden of AF was signiﬁcantly lower in PAR group than in PVI
group (0.9%  2.3% vs 4.9%  9.9%; 90th percentile, 5.5% vs
19.6%; P ¼0.008).
CONCLUSIONS PAR ablation is a simple, safe, and effective strategy
for the treatment of paroxysmal AF with better long-term outcome
than PVI. PAR ablation might exhibit the beneﬁcial effect on AF
management through multiple mechanisms.GW26-e0725
Feasibility and Clinical Application of MSCT Three-dimensional Imaging In
Percutaneous Left Atrial Appendage Closure
Dong Yang, Zirong Wang, Zhao Xu, Tingting Yuan, Xu Wang,
Jianping Ding, Xingwei Zhang
Afﬁliated Hospital of Hangzhou Normal University, School of Medicine,
Hangzhou Normal University, Hangzhou, China
OBJECTIVES The three-dimensional(3D) structures of left atrial
appendage (LAA) in atrial ﬁbrillation patients were reconstructed by
Multi-slice computed tomography (MSCT) imaging system, aiming at
exploring the feasibility and clinical applied value in percutaneous
left atrial appendage closure.
METHODS Inclusion criteria were: voluntary patients with both
atrial ﬁbrillation and indication for LAA closure aging from 40 to 85
years old with contraindication for oral anticoagulants or unwill-
ingness to take long-term oral anticoagulation therapy. With the
three-dimensional structures of LAA which are reconstructed from
the imaging of MSCT by post-processing workstation, the measure-
ment of diameter and depth of LAA is compared between the way of
preoperatively spatial vector and postoperatively both trans-
esophageal echocardiography(TEE) and radiography, aiming at
selecting suitable size and location of LAA closure device. The de-
vices were planted at the ostium of the LAA. The TEE and (or) CT
three-dimensional reconstruction were rechecked, and follow-up of
major cardiovascular events within 3 months after implantation was
recorded.
RESULTS 17 atrial ﬁbrillation patients were enrolled (average
age:69.08.83 years old). 15 of them were non-valvular atrial ﬁbril-
lation patients [CHADS2-VAS score (3.71.78) and HAS-BLED score
(2.61.33)]. Ten of these 17 patients were successfully implanted with
the WATCHMAN LAA closure devices. Nine of the ten were with non-
valvular atrial ﬁbrillation with average CHADS2-VAS score (3.21.69)
and HAS-BLED score (2.71.63). The rest one was a valvular atrial
ﬁbrillation patient with the history of the percutaneous balloon mitral
valvuloplasty (PBMV) resulting in the lack of surgical indications of
mitral valve replacement (MVR). No blood leakage was found around
the device by regular postoperative TEE and LAA radiography exam-
inations among 10 patients. Two methods under AW4.4 system
showed high repeatability and no obvious difference with the ﬁnal
device size. There existed difference with statistical signiﬁcance
compared to TEE (All P<0.05). Thus, MSCT imaging may be superior
to the TEE. There were no complications of bleeding, embolism, or
stroke during both peri-operative period and three-month follow-up
time. Also, recheck by TEE and(or) CT 3D reconstruction three months
after procedure showed no blood leakage among 10 atrial ﬁbrillation
patients.
CONCLUSIONS Preoperative MSCT three-dimensional reconstruction
of LAA among atrial ﬁbrillation patients shows the three dimensional
structure and provides essential information guiding the successful
LAA closures. Reconstruction after the procedure provides reliable
reference for follow-up.
